Therapeutic Category
Anti-diabetic
SIZENTA
DPP-4 Inhibitor for Type 2 Diabetes
Anti-diabetic Brand
SIZENTA
SIZENTA contains sitagliptin, a DPP-4 inhibitor that helps lower blood glucose levels in adults with type 2 diabetes mellitus, used alone or with other antidiabetic medicines.
Dosage form
Tablets
Strengths Available
50mg, 100mg
Pack sizes
Pack of 3x10 Tablets
Therapeutic Indications
- SIZENTA is indicated, together with diet and exercise, to improve glycaemic control in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic medicines.
Brand Name
SIZENTA
Product Name
SIZENTA 50
Generic Name
Sitagliptin Tablets USP 50mg
Dosage Form
Tablets
Pack Size
Pack of 3x10 Tablets
Therapeutic Indication
Indicated, together with diet and exercise, to improve glycaemic control in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic medicines.
Dosage and Method of Administration
Adults: One 50mg tablet once daily,
Mode of Administration
For oral use only.
Brand Name
SIZENTA
Product Name
SIZENTA 100
Generic Name
Sitagliptin Tablets USP 100mg
Dosage Form
Tablets
Pack Size
Pack of 3x10 Tablets
Therapeutic Indication
Indicated, together with diet and exercise, to improve glycaemic control in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic medicines.
Dosage and Method of Administration
One 100 mg tablet once daily, with or without food. This is the usual starting and maintenance dose.
Mode of Administration
For oral use only.